RETRACTED ARTICLE: Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector
本文针对印度制药行业采用工业4.0技术缓慢的问题，提出一个整合AHP、CODAS和DEMATEL方法的障碍解决方案框架，发现成本高昂是最大障碍，客户意识与满意度是潜在解决方案。
Industry 4.0 (I4.0) is helping production units to become smarter using cyber-physical systems and cognitive intelligence. The advanced diagnostics with I4.0 technologies (I4.0t) help in making the process highly flexible, resilient and autonomous. Still, the adoption of I4.0t especially in emerging economies like India is at a very slow pace. The present research has used an integrated approach i.e., Analytical Hierarchy Process-Combinative Distance-Based Assessment-Decision-Making Trial and Evaluation Laboratory to propose a barrier solution framework using data from pharmaceutical manufacturing sector. The findings reveal that “Costly venture” is found to be the most critical deterrent while “Customer awareness and satisfaction” is one of the potential solutions for I4.0t adoption. Further, lack of standardisation and fair benchmarking policies especially in the context of developing economies needs immediate attention. This article concludes by proposing a framework which will help to move from I4.0 towards Industry 4.0 + (I4.0+) which emphasises on role of collaboration between man and machine. And leads to sustainable supply chain management.